| Literature DB >> 32101731 |
Sören Reinke1, Mary Linge1, Hans H Diebner2, Hella Luksch1, Silke Glage3, Anne Gocht1, Avril A B Robertson4, Matthew A Cooper5, Sigrun R Hofmann1, Ronald Naumann6, Mihail Sarov7, Rayk Behrendt8, Axel Roers8, Frank Pessler9, Joachim Roesler1, Angela Rösen-Wolff1, Stefan Winkler10.
Abstract
Pro-inflammatory caspase-1 is a key player in innate immunity. Caspase-1 processes interleukin (IL)-1β and IL-18 to their mature forms and triggers pyroptosis. These caspase-1 functions are linked to its enzymatic activity. However, loss-of-function missense mutations in CASP1 do not prevent autoinflammation in patients, despite decreased IL-1β production. In vitro data suggest that enzymatically inactive caspase-1 drives inflammation via enhanced nuclear factor κB (NF-κB) activation, independent of IL-1β processing. Here, we report two mouse models of enzymatically inactive caspase-1-C284A, demonstrating the relevance of this pathway in vivo. In contrast to Casp1-/- mice, caspase-1-C284A mice show pronounced hypothermia and increased levels of the pro-inflammatory cytokines tumor necrosis factor alpha (TNF-α) and IL-6 when challenged with lipopolysaccharide (LPS). Caspase-1-C284A signaling is RIP2 dependent and mediated by TNF-α but independent of the NLRP3 inflammasome. LPS-stimulated whole blood from patients carrying loss-of-function missense mutations in CASP1 secretes higher amounts of TNF-α. Taken together, these results reveal non-canonical caspase-1 signaling in vivo.Entities:
Keywords: NF-κB; Rip2; TNF-α; caspase-1; enzymatic activity; non-canonical caspase-1 signaling
Mesh:
Substances:
Year: 2020 PMID: 32101731 DOI: 10.1016/j.celrep.2020.01.090
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423